Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC K-Dur Case Nears Trial: WLF Says Agency Is Challenging Judiciary

Executive Summary

The Federal Trade Commission's K-Dur case breaks new ground by challenging the validity of a court-approved settlement agreement, the Washington Legal Foundation suggested in a recent backgrounder

You may also be interested in...



FTC Patent/Competition Hearings To Include Discussion Of “Patent Thicket”

The increase in patents issued in the U.S. will be one topic of discussion during hearings on the relationship between intellectual property and competition sponsored by the Federal Trade Commission and the Justice Department Antitrust Division

FTC Patent/Competition Hearings To Include Discussion Of “Patent Thicket”

The increase in patents issued in the U.S. will be one topic of discussion during hearings on the relationship between intellectual property and competition sponsored by the Federal Trade Commission and the Justice Department Antitrust Division

AHP Exiting Oral Generics Business; K-Dur Settlement With FTC Near

American Home Products is phasing out its oral solid dosage form generic drug business, the company said in documents filed as part of the Federal Trade Commission suit against ESI Lederle

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel